Eflornithine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Eflornithine. Educational only — not medical advice.
Labeled uses
VANIQA (eflornithine hydrochloride) Cream, 13.9% is indicated for the reduction of unwanted facial hair in women. VANIQA has only been studied on the face and adjacent involved areas under the chin of affected individuals. Usage should be limited to these areas of involvement.
Source: FDA labeling via NIH DailyMed (set a2c3d206…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.